Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | heat shock protein 90 | 0.0088 | 0.608 | 0.6894 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.0111 | 0.8818 | 1 |
Schistosoma mansoni | heat shock protein | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Echinococcus multilocularis | heat shock protein 90 | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0088 | 0.608 | 0.655 |
Echinococcus granulosus | heat shock protein 75 kDa mitochondrial | 0.0045 | 0.0881 | 0.0999 |
Leishmania major | lipophosphoglycan biosynthetic protein, putative,heat shock protein 90, putative,glucose regulated protein 94, putative | 0.0088 | 0.608 | 0.655 |
Trypanosoma brucei | heat shock protein 90, putative | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Loa Loa (eye worm) | heat shock protein 90 | 0.0111 | 0.8818 | 0.8818 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0068 | 0.362 | 0.345 |
Echinococcus granulosus | heat shock protein 90 | 0.0111 | 0.8818 | 1 |
Echinococcus multilocularis | heat shock protein 90 | 0.0088 | 0.608 | 0.6894 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.012 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Schistosoma mansoni | heat shock protein | 0.0045 | 0.0881 | 0.0999 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Mycobacterium tuberculosis | Probable chaperone protein HtpG (heat shock protein) (HSP90 family protein) (high temperature protein G) | 0.0088 | 0.608 | 0.5 |
Trichomonas vaginalis | heat shock protein, putative | 0.0088 | 0.608 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Plasmodium falciparum | heat shock protein 90 | 0.0111 | 0.8818 | 1 |
Treponema pallidum | heat shock protein 90 | 0.0088 | 0.608 | 0.5 |
Plasmodium vivax | endoplasmin, putative | 0.0111 | 0.8818 | 1 |
Echinococcus granulosus | heat shock protein | 0.0111 | 0.8818 | 1 |
Toxoplasma gondii | heat shock protein 90, putative | 0.0111 | 0.8818 | 1 |
Echinococcus granulosus | heat shock protein heat shock protein 90 alpha | 0.0088 | 0.608 | 0.6894 |
Trichomonas vaginalis | endoplasmin, putative | 0.0068 | 0.362 | 0.345 |
Brugia malayi | Endoplasmin precursor | 0.0111 | 0.8818 | 0.8818 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Echinococcus multilocularis | endoplasmin | 0.0088 | 0.608 | 0.6894 |
Echinococcus multilocularis | heat shock protein 75 kDa, mitochondrial | 0.0045 | 0.0881 | 0.0999 |
Plasmodium vivax | heat shock protein 86, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Loa Loa (eye worm) | heat shock protein 75 | 0.0045 | 0.0881 | 0.0881 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0082 | 0.5371 | 0.5371 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.5371 | 0.5371 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Mycobacterium ulcerans | heat shock protein 90 | 0.0088 | 0.608 | 0.5 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Schistosoma mansoni | endoplasmin | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0111 | 0.8818 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.5371 | 0.6091 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Echinococcus granulosus | endoplasmin | 0.0088 | 0.608 | 0.6894 |
Mycobacterium leprae | PROBABLE CHAPERONE PROTEIN HTPG (HEAT SHOCK PROTEIN) (HSP90 FAMILY PROTEIN) (HIGH TEMPERATURE PROTEIN G) | 0.0088 | 0.608 | 0.5 |
Onchocerca volvulus | Heat shock protein 75 kDa, mitochondrial homolog | 0.0045 | 0.0881 | 0.5 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0088 | 0.608 | 0.655 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.012 | 1 | 1 |
Trypanosoma brucei | Heat shock protein 83, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma brucei | heat shock protein 90, putative | 0.0111 | 0.8818 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0088 | 0.608 | 0.655 |
Schistosoma mansoni | endoplasmin | 0.0111 | 0.8818 | 1 |
Brugia malayi | heat shock protein 90 | 0.0111 | 0.8818 | 0.8818 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Toxoplasma gondii | heat shock protein HSP90 | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Echinococcus multilocularis | heat shock protein | 0.0111 | 0.8818 | 1 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | Heat shock protein 83, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0088 | 0.608 | 0.655 |
Brugia malayi | Hsp90 protein | 0.0045 | 0.0881 | 0.0881 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0111 | 0.8818 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Plasmodium falciparum | endoplasmin, putative | 0.0068 | 0.362 | 0.345 |
Loa Loa (eye worm) | endoplasmin | 0.0111 | 0.8818 | 0.8818 |
Wolbachia endosymbiont of Brugia malayi | heat shock protein 90 | 0.0088 | 0.608 | 0.5 |
Leishmania major | heat shock protein 83-1 | 0.0111 | 0.8818 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0065 | 0.3308 | 0.3058 |
Schistosoma mansoni | heat shock protein | 0.0111 | 0.8818 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0111 | 0.8818 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.7783 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.